Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial

Xingdang Liu, Congjin Liu, Hongyu Li, Xueqin Xiang, Zhifu Luo, Yuankai Wang and John Zaknun
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1752;
Xingdang Liu
1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Congjin Liu
1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongyu Li
2Department of Isotope, China Institute of Atomic Energy, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xueqin Xiang
2Department of Isotope, China Institute of Atomic Energy, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhifu Luo
2Department of Isotope, China Institute of Atomic Energy, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuankai Wang
1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Zaknun
3Nuclear Medicine Section, Division of Human Health, IAEA, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 1752

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Xingdang Liu1,
  2. Congjin Liu1,
  3. Hongyu Li2,
  4. Xueqin Xiang2,
  5. Zhifu Luo2,
  6. Yuankai Wang1 and
  7. John Zaknun3
  1. 1Department of Nuclear Medicine, Hua Shan Hospital, Fudan University, Shanghai, China
  2. 2Department of Isotope, China Institute of Atomic Energy, Beijing, China
  3. 3Nuclear Medicine Section, Division of Human Health, IAEA, Vienna, Austria

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to May 2025

AbstractFullPdf
Dec 2014600
Jan 2015400
Mar 2015100
May 2015100
Jun 2015500
Jul 2015400
Aug 2015100
Sep 2015700
Nov 2015200
Apr 2016300
Aug 2016200
Sep 2016200
Oct 2016100
Jan 2017200
Feb 2017400
Mar 2017100
Apr 2017200
May 2017100
Jun 2017600
Jul 2017100
Aug 2017100
Oct 2017100
Nov 2017200
Dec 2017100
Jan 2018800
Mar 2018100
Apr 2018100
Jun 2018300
Jul 2018400
Aug 2018300
Sep 2018200
Oct 2018500
Nov 2018800
Dec 2018100
Jan 2019500
Feb 2019400
Mar 2019100
Apr 2019100
May 2019100
Jun 2019100
Aug 2019100
Sep 2019300
Oct 2019200
Dec 2019100
Jan 2020200
Feb 2020900
Mar 20201900
Apr 20202100
May 20201400
Jun 2020300
Jul 2020200
Aug 20201800
Sep 20203200
Oct 20201300
Nov 20201900
Dec 2020500
Jan 2021200
Feb 20212200
Mar 20211400
Apr 20211500
May 20211000
Jun 2021200
Jul 20211500
Aug 20212900
Sep 20211100
Oct 20211100
Nov 20216700
Dec 20213500
Jan 20225900
Feb 20222100
Mar 20221300
Apr 2022900
May 20222300
Jun 2022100
Jul 2022100
Aug 2022500
Sep 2022300
Oct 2022100
Dec 2022100
Feb 2023200
Mar 2023200
Apr 2023100
May 2023200
Jun 2023200
Jul 2023200
Aug 2023500
Sep 2023600
Oct 2023500
Nov 2023400
Dec 2023800
Jan 2024200
Feb 2024800
Mar 2024400
Apr 20241400
May 2024200
Jun 2024700
Jul 2024100
Aug 2024600
Sep 2024300
Oct 2024500
Nov 2024200
Dec 2024800
Feb 2025200
Mar 2025400
Apr 2025600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial
Xingdang Liu, Congjin Liu, Hongyu Li, Xueqin Xiang, Zhifu Luo, Yuankai Wang, John Zaknun
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1752;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial
Xingdang Liu, Congjin Liu, Hongyu Li, Xueqin Xiang, Zhifu Luo, Yuankai Wang, John Zaknun
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1752;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

  • Characterization of 177Lu-Affibody-HSA bioconjugate for radionuclide therapy of EGFR-expressing head and neck carcinomas
  • Low-dose hyper-radiosensitivity model for 131I radioimmunotherapy of non-Hodgkin’s lymphoma
  • Comparative therapeutic efficacy of 188Re-liposome and 5-FU in CT26-luc lung-metastatic mice model via intravenous route
Show more Oncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

Radiopharmaceutical Therapy Posters

  • Characterization of 177Lu-Affibody-HSA bioconjugate for radionuclide therapy of EGFR-expressing head and neck carcinomas
  • Low-dose hyper-radiosensitivity model for 131I radioimmunotherapy of non-Hodgkin’s lymphoma
  • Comparative therapeutic efficacy of 188Re-liposome and 5-FU in CT26-luc lung-metastatic mice model via intravenous route
Show more Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire